Genitope Corporation

Genitope Corporation

Genitope is a drug development company in arrested development. It had hoped to find new ways to fight cancer with old weapons, but now it is just hoping to find a future. The company was researching immunotherapy treatments for cancer, using the body's own immune system to fight tumors. Genitope's leading drug candidate, MyVax, was a patient-specific immunotherapy that would specify the genetic makeup of the tumor, activate the patient's immune system to attack it, and cause no damage to cells other than the tumor. However, the drug did not do well in early clinical trials, and when the FDA requested additional trials for further review, Genitope chose to scrap the whole program.

Contact Details

Office Address

Genitope Corporation
6900 Dumbarton Cr
Fremont, CA, USA 94555-3651
Phone: (510) 284-3000
Fax: (510) 284-3100

Executives

Chairman, CEO, Interim CFO, and Principal Financial Officer

Dan W. Denney Jr.

VP Information Technology

H. David Miller

Business Reviews for Genitope Corporation

Related Companies